AR039286A1 - Formulacion de aerosol para inhalacion que contiene una sal de tiotropio - Google Patents
Formulacion de aerosol para inhalacion que contiene una sal de tiotropioInfo
- Publication number
- AR039286A1 AR039286A1 ARP030101267A ARP030101267A AR039286A1 AR 039286 A1 AR039286 A1 AR 039286A1 AR P030101267 A ARP030101267 A AR P030101267A AR P030101267 A ARP030101267 A AR P030101267A AR 039286 A1 AR039286 A1 AR 039286A1
- Authority
- AR
- Argentina
- Prior art keywords
- aerosol formulation
- tiotropio
- salt
- inhalation containing
- inhalation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nozzles (AREA)
Abstract
Formulación de aerosol, exenta de gas propulsor, de una sal farmacéuticamente aceptable de tiotropio, disuelta en agua. La formulación de acuerdo con la presente es apropiada, en especial, para nebulizar la sustancia activa por medio de un pulverizador, con el fin de administrar la sustancia activa mediante inhalación, en el caso de presentarse las indicaciones de asma y/o COPD.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10216036A DE10216036A1 (de) | 2002-04-11 | 2002-04-11 | Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR039286A1 true AR039286A1 (es) | 2005-02-16 |
Family
ID=28458728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030101267A AR039286A1 (es) | 2002-04-11 | 2003-04-11 | Formulacion de aerosol para inhalacion que contiene una sal de tiotropio |
Country Status (32)
| Country | Link |
|---|---|
| EP (2) | EP1496876B1 (es) |
| JP (1) | JP2005531528A (es) |
| KR (1) | KR100997219B1 (es) |
| CN (1) | CN1309378C (es) |
| AR (1) | AR039286A1 (es) |
| AT (1) | ATE389391T1 (es) |
| AU (1) | AU2003222791B2 (es) |
| BR (1) | BR0309080A (es) |
| CA (1) | CA2473815C (es) |
| CO (1) | CO5611150A2 (es) |
| CY (1) | CY1108133T1 (es) |
| DE (2) | DE10216036A1 (es) |
| DK (1) | DK1496876T3 (es) |
| EA (1) | EA007228B1 (es) |
| EC (1) | ECSP045358A (es) |
| ES (1) | ES2303897T3 (es) |
| HR (1) | HRP20040932B1 (es) |
| ME (1) | ME00359B (es) |
| MX (1) | MXPA04009818A (es) |
| MY (1) | MY137249A (es) |
| NO (1) | NO334915B1 (es) |
| PE (1) | PE20030970A1 (es) |
| PL (1) | PL371204A1 (es) |
| PT (1) | PT1496876E (es) |
| RS (1) | RS50923B (es) |
| SA (1) | SA03240192B1 (es) |
| SI (1) | SI1496876T1 (es) |
| TW (1) | TWI344851B (es) |
| UA (1) | UA78994C2 (es) |
| UY (1) | UY27754A1 (es) |
| WO (1) | WO2003084519A2 (es) |
| ZA (1) | ZA200405721B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8686148B2 (en) | 2003-11-03 | 2014-04-01 | Boehringer Ingelheim International Gmbh | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof |
| CA2617717C (en) * | 2005-08-06 | 2014-02-11 | Boehringer Ingelheim International Gmbh | Use of tiotropium salts in the treatment of severe persistant asthma |
| US20070088030A1 (en) | 2005-10-10 | 2007-04-19 | Barbara Niklaus-Humke | Aerosol formulations for the inhalation of beta-agonists |
| EP1905440A1 (de) * | 2006-09-06 | 2008-04-02 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen |
| EP2044967A1 (de) * | 2007-10-01 | 2009-04-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Zerstäuber |
| WO2013127738A1 (de) | 2012-02-28 | 2013-09-06 | Boehringer Ingelheim International Gmbh | Neue treibgashaltige tiotropium-formulierung |
| RU2493827C1 (ru) * | 2012-10-03 | 2013-09-27 | Шолекс Девелопмент Гмбх | Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида |
| WO2015065223A1 (ru) * | 2013-10-28 | 2015-05-07 | Шолекс Девелопмент Гмбх | Стабильный раствор фенотерола гидробромида |
| WO2015065219A1 (ru) * | 2013-10-28 | 2015-05-07 | Шолекс Девелопмент Гмбх | Раствор ипратропия бромида |
| GB201507686D0 (en) * | 2015-05-05 | 2015-06-17 | Norton Healthcare Ltd | A stable tiotropium nebuliser solution |
| CN109963557A (zh) * | 2016-11-16 | 2019-07-02 | 格兰马克专业公司 | 雾化的噻托铵 |
| CN115209872B (zh) * | 2020-03-19 | 2024-08-02 | 广州谷森制药有限公司 | 含有酒石酸左旋沙丁胺醇的可吸入制剂 |
| CN114259481A (zh) * | 2021-11-26 | 2022-04-01 | 南京华盖制药有限公司 | 一种奥达特罗复方吸入溶液 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931041C2 (de) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
| IL107120A (en) | 1992-09-29 | 1997-09-30 | Boehringer Ingelheim Int | Atomising nozzle and filter and spray generating device |
| DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| DE19536903C2 (de) | 1995-10-04 | 1998-09-10 | Boehringer Ingelheim Int | Vorrichtung zum Haltern eines fluidischen Bauteils |
| DE19545226C1 (de) | 1995-12-05 | 1997-06-19 | Boehringer Ingelheim Int | Sperrspannwerk für einen federbetätigten Abtrieb |
| DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| DE19742439C1 (de) | 1997-09-26 | 1998-10-22 | Boehringer Ingelheim Int | Mikrostrukturiertes Filter |
| DE19847968A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen |
| CN101292964A (zh) * | 2000-10-31 | 2008-10-29 | 贝林格尔英格海姆法玛两合公司 | 包含噻托铵盐溶液的可吸入制剂 |
-
2002
- 2002-04-11 DE DE10216036A patent/DE10216036A1/de not_active Withdrawn
-
2003
- 2003-02-04 UA UA20041109194A patent/UA78994C2/uk unknown
- 2003-04-02 PL PL03371204A patent/PL371204A1/xx not_active Application Discontinuation
- 2003-04-02 JP JP2003581759A patent/JP2005531528A/ja active Pending
- 2003-04-02 EA EA200401305A patent/EA007228B1/ru not_active IP Right Cessation
- 2003-04-02 AU AU2003222791A patent/AU2003222791B2/en not_active Expired
- 2003-04-02 HR HRP20040932AA patent/HRP20040932B1/hr not_active IP Right Cessation
- 2003-04-02 SI SI200331206T patent/SI1496876T1/sl unknown
- 2003-04-02 DK DK03718724T patent/DK1496876T3/da active
- 2003-04-02 CA CA2473815A patent/CA2473815C/en not_active Expired - Fee Related
- 2003-04-02 MX MXPA04009818A patent/MXPA04009818A/es active IP Right Grant
- 2003-04-02 EP EP03718724A patent/EP1496876B1/de not_active Expired - Lifetime
- 2003-04-02 CN CNB038082330A patent/CN1309378C/zh not_active Ceased
- 2003-04-02 ES ES03718724T patent/ES2303897T3/es not_active Expired - Lifetime
- 2003-04-02 PT PT03718724T patent/PT1496876E/pt unknown
- 2003-04-02 DE DE50309414T patent/DE50309414D1/de not_active Expired - Lifetime
- 2003-04-02 AT AT03718724T patent/ATE389391T1/de active
- 2003-04-02 WO PCT/EP2003/003438 patent/WO2003084519A2/de not_active Ceased
- 2003-04-02 KR KR1020047016052A patent/KR100997219B1/ko not_active Expired - Lifetime
- 2003-04-02 ME MEP-2008-543A patent/ME00359B/me unknown
- 2003-04-02 BR BR0309080-9A patent/BR0309080A/pt not_active Application Discontinuation
- 2003-04-02 EP EP08152138A patent/EP1949892A1/de not_active Withdrawn
- 2003-04-02 RS YUP-879/04A patent/RS50923B/sr unknown
- 2003-04-09 MY MYPI20031314A patent/MY137249A/en unknown
- 2003-04-09 PE PE2003000359A patent/PE20030970A1/es not_active Application Discontinuation
- 2003-04-09 UY UY27754A patent/UY27754A1/es not_active Application Discontinuation
- 2003-04-10 TW TW092108240A patent/TWI344851B/zh not_active IP Right Cessation
- 2003-04-11 AR ARP030101267A patent/AR039286A1/es not_active Application Discontinuation
- 2003-07-07 SA SA03240192A patent/SA03240192B1/ar unknown
-
2004
- 2004-07-19 ZA ZA200405721A patent/ZA200405721B/en unknown
- 2004-09-23 NO NO20044001A patent/NO334915B1/no not_active IP Right Cessation
- 2004-10-08 CO CO04100971A patent/CO5611150A2/es active IP Right Grant
- 2004-10-11 EC EC2004005358A patent/ECSP045358A/es unknown
-
2008
- 2008-06-11 CY CY20081100623T patent/CY1108133T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR039286A1 (es) | Formulacion de aerosol para inhalacion que contiene una sal de tiotropio | |
| ATE342053T1 (de) | Formulierungen zur inhalation | |
| ES2176355T3 (es) | Formulaciones de aerosol de peptidos y proteinas. | |
| ECSP088404A (es) | Nuevos derivados de imidazo[4,5-b]piridina como inhibidores de la glucógeno sintasa quinasa 3, para uso en el tratamiento de demencia y trastornos neurodegenerativos | |
| ATE291898T1 (de) | Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason | |
| IT1317846B1 (it) | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. | |
| AR101593A2 (es) | Formulación superfina de formoterol | |
| ATE554746T1 (de) | Pharmazeutische zusammensetzungen mit cyclosporin | |
| MX9704550A (es) | Formulaciones de medicamentos en aerosol. | |
| CO5611092A2 (es) | Formulacion superfina de formoterol | |
| CY1108137T1 (el) | Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα | |
| IT1317904B1 (it) | Formulazione farmaceutica di propionato di fluticasone. | |
| ES2106360T3 (es) | Formulaciones farmaceuticas de aerosol que contienen dipropionato de beclometasona. | |
| UY27740A1 (es) | Nuevos compuestos | |
| NZ592705A (en) | 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication | |
| PE20240808A1 (es) | Composiciones, metodos y sistemas para la administracion de farmacos en aerosol | |
| BRPI0515103A (pt) | composição farmacêutica, inalador, processos para preparar o mesmo, e uma composição farmacêutica, e, uso de uma composição farmacêutica | |
| BR0317340A (pt) | Formulações de hfc em solução contendo tiotrópio | |
| ECSP088732A (es) | Aerosoles dosificadores para la administración de preparaciones farmacéuticas | |
| AR040450A1 (es) | Formulacion superfina de salmeterol | |
| AR085059A1 (es) | Composicion resistente a la corrosion y farmaceuticamente estable para inhalador presurizado de dosis medida y metodo para generarla | |
| MXPA02001804A (es) | Composicion para inhalacion que comprende delta-9-tetrahidrocanabinol en un solvente semi-acuoso. | |
| NO20074854L (no) | Farmasoytiske aerosolformuleringer for komprimerte, utmalte doseinhalatorer omfattende et sekvestreringsmiddel | |
| GT200300017A (es) | Sistema de suministro osmotico | |
| ES2180446A1 (es) | Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |